Charles Schwab’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-210,628
| Closed | -$780K | – | 3181 |
|
|
2016
Q1 | $780K | Sell |
210,628
-95,703
| -31% | -$354K | ﹤0.01% | 2421 |
|
|
2015
Q4 | $3.09M | Buy |
306,331
+130,622
| +74% | +$1.32M | ﹤0.01% | 1829 |
|
|
2015
Q3 | $2.39M | Buy |
175,709
+78,642
| +81% | +$1.07M | ﹤0.01% | 1967 |
|
|
2015
Q2 | $1.84M | Buy |
97,067
+3,032
| +3% | +$57.5K | ﹤0.01% | 2142 |
|
|
2015
Q1 | $2.46M | Buy |
94,035
+4,760
| +5% | +$125K | ﹤0.01% | 1939 |
|
|
2014
Q4 | $1.87M | Buy |
89,275
+13,310
| +18% | +$279K | ﹤0.01% | 2050 |
|
|
2014
Q3 | $2.54M | Buy |
75,965
+4,713
| +7% | +$157K | ﹤0.01% | 1826 |
|
|
2014
Q2 | $2.29M | Sell |
71,252
-276
| -0.4% | -$8.86K | ﹤0.01% | 1913 |
|
|
2014
Q1 | $3.3M | Buy |
71,528
+3,778
| +6% | +$174K | 0.01% | 1645 |
|
|
2013
Q4 | $4.81M | Buy |
67,750
+2,278
| +3% | +$162K | 0.01% | 1287 |
|
|
2013
Q3 | $5.91M | Buy |
65,472
+11,592
| +22% | +$1.05M | 0.01% | 1032 |
|
|
2013
Q2 | $3.71M | Buy |
+53,880
| New | +$3.71M | 0.01% | 1304 |
|